MAIA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

MAIAMAIA Biotechnology, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

MAIAMAIA Biotechnology, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MAIA: latest quarter not drawable.Method ›

Price

rebased to 0%

MAIA, solidLLY, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MAIA 0

None

Shared 0

No disclosed counterparties: MAIA.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

MAIAMAIA Biotechnology, Inc.

1.11▼−5.93%· post 1.11

Mkt cap$66.9MRevenue—Revenue—

LLYELI Lilly & Co

1,412.87▲+2.85%· post 1,417.05

ClosedOct 30 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedOct 30 '26

MAIAMAIA Biotechnology, Inc.

LLYELI Lilly & Co

1.11▼−5.93%post 1.11

Price

1,412.87▲+2.85%post 1,417.05

$66.9M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

MAIA1.11▼−5.93%vsLLY1,412.87▲+2.85%ClosedOct 30 '26